These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37329382)

  • 1. miR-218-5p and miR-320a-5p as Biomarkers for Brain Disorders: Focus on the Major Depressive Disorder and Parkinson's Disease.
    Wan Z; Rasheed M; Li Y; Li Q; Wang P; Li J; Chen Z; Du J; Deng Y
    Mol Neurobiol; 2023 Oct; 60(10):5642-5654. PubMed ID: 37329382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression and significance of miRNAs in plasma extracellular vesicles of patients with Parkinson's disease.
    Xie S; Niu W; Xu F; Wang Y; Hu S; Niu C
    Int J Neurosci; 2022 Jul; 132(7):673-688. PubMed ID: 33045885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Several miRNAs derived from serum extracellular vesicles are potential biomarkers for early diagnosis and progression of Parkinson's disease.
    He S; Huang L; Shao C; Nie T; Xia L; Cui B; Lu F; Zhu L; Chen B; Yang Q
    Transl Neurodegener; 2021 Jul; 10(1):25. PubMed ID: 34315539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and Exosomal miR-7-1-5p and miR-223-3p as Possible Biomarkers for Parkinson's Disease.
    Citterio LA; Mancuso R; Agostini S; Meloni M; Clerici M
    Biomolecules; 2023 May; 13(5):. PubMed ID: 37238734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptomics and Proteomics Approach for the Identification of Altered Blood microRNAs and Plasma Proteins in Parkinson's Disease.
    Yadav SK; Jauhari A; Singh N; Pandey A; Sarkar S; Pandey S; Garg RK; Parmar D; Yadav S
    Cell Mol Neurobiol; 2023 Oct; 43(7):3527-3553. PubMed ID: 37219663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression of microRNA-132-3p and microRNA-146a-5p in Parkinson's disease patients.
    Shu Y; Qian J; Wang C
    Open Life Sci; 2020; 15(1):647-653. PubMed ID: 33817253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of miR-137 and miR-124 are associated with Parkinson's disease but not with Parkinson's disease with depression.
    Li N; Pan X; Zhang J; Ma A; Yang S; Ma J; Xie A
    Neurol Sci; 2017 May; 38(5):761-767. PubMed ID: 28181066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative analysis of potential biomarkers and immune cell infiltration in Parkinson's disease.
    Chen X; Cao W; Zhuang Y; Chen S; Li X
    Brain Res Bull; 2021 Dec; 177():53-63. PubMed ID: 34536521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pyroptosis mediated biomarker pattern: an emerging diagnostic approach for Parkinson's disease.
    Liang J; Wan Z; Qian C; Rasheed M; Cao C; Sun J; Wang X; Chen Z; Deng Y
    Cell Mol Biol Lett; 2024 Jan; 29(1):7. PubMed ID: 38172670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs in Parkinson's disease: a systematic review and diagnostic accuracy meta-analysis.
    Guévremont D; Roy J; Cutfield NJ; Williams JM
    Sci Rep; 2023 Sep; 13(1):16272. PubMed ID: 37770507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum miR-30c-5p is a potential biomarker for multiple system atrophy.
    Vallelunga A; Iannitti T; Dati G; Capece S; Maugeri M; Tocci E; Picillo M; Volpe G; Cozzolino A; Squillante M; Cicarelli G; Barone P; Pellecchia MT
    Mol Biol Rep; 2019 Apr; 46(2):1661-1666. PubMed ID: 30810945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying the potential role of serum miR-20a as a biomarker for olfactory dysfunction in patients with Parkinson's disease.
    Liu H; Zhao H; Bao Y; Yang J; Xie H; Huang D
    Eur Arch Otorhinolaryngol; 2023 Oct; 280(10):4509-4517. PubMed ID: 37258792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma miR-203a-3p as a Novel Predictor of Dementia in Patients with Parkinson's Disease.
    Hsu YF; Lin SP; Chu YT; Tsai YT; Huang JW; Phoa FKH; Wu RM
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson's disease.
    Uwatoko H; Hama Y; Iwata IT; Shirai S; Matsushima M; Yabe I; Utsumi J; Sasaki H
    Mol Brain; 2019 May; 12(1):49. PubMed ID: 31088501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study.
    Manna I; Quattrone A; De Benedittis S; Vescio B; Iaccino E; Quattrone A
    Parkinsonism Relat Disord; 2021 Dec; 93():77-84. PubMed ID: 34839044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression Profiling of Blood microRNAs 885, 361, and 17 in the Patients with the Parkinson's disease: Integrating Interaction Data to Uncover the Possible Triggering Age-Related Mechanisms.
    Behbahanipour M; Peymani M; Salari M; Hashemi MS; Nasr-Esfahani MH; Ghaedi K
    Sci Rep; 2019 Sep; 9(1):13759. PubMed ID: 31551498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of differentially expressed brain-enriched microRNAs in the plasma of PD patients.
    Ravanidis S; Bougea A; Papagiannakis N; Koros C; Simitsi AM; Pachi I; Breza M; Stefanis L; Doxakis E
    Ann Clin Transl Neurol; 2020 Sep; 7(9):1594-1607. PubMed ID: 32860338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum miR-96-5P and miR-339-5P Are Potential Biomarkers for Multiple System Atrophy and Parkinson's Disease.
    Vallelunga A; Iannitti T; Capece S; Somma G; Russillo MC; Foubert-Samier A; Laurens B; Sibon I; Meissner WG; Barone P; Pellecchia MT
    Front Aging Neurosci; 2021; 13():632891. PubMed ID: 34381349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson's Disease and Multiple System Atrophy.
    Marques TM; Kuiperij HB; Bruinsma IB; van Rumund A; Aerts MB; Esselink RAJ; Bloem BR; Verbeek MM
    Mol Neurobiol; 2017 Dec; 54(10):7736-7745. PubMed ID: 27844283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender differences in microRNA expression in levodopa-naive PD patients.
    Vallelunga A; Iannitti T; Somma G; Russillo MC; Picillo M; De Micco R; Vacca L; Cilia R; Cicero CE; Zangaglia R; Lazzeri G; Galantucci S; Radicati FG; De Rosa A; Amboni M; Scaglione C; Tessitore A; Stocchi F; Eleopra R; Nicoletti A; Pacchetti C; Di Fonzo A; Volontè MA; Barone P; Pellecchia MT
    J Neurol; 2023 Jul; 270(7):3574-3582. PubMed ID: 37052669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.